New COVID-19 variants raise questions around vaccines, WHO says | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
May 29, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, MAY 29, 2025
New COVID-19 variants raise questions around vaccines, WHO says

Coronavirus chronicle

TBS Report 
09 February, 2021, 09:50 am
Last modified: 09 February, 2021, 09:55 am

Related News

  • Uncertainty in aid commitments threatens Bangladesh's progress in maternal health: UNICEF, UNFPA, WHO
  • 'History will not forgive' failure to seal pandemic deal: WHO chief
  • Japan provides $3.2m to WHO as assistance to ensure quality health services in Cox's Bazar, Bhasan Char
  • Argentina to withdraw from WHO after Trump exit, citing 'deep differences'
  • WHO proposes budget cut after US exit, defends its work

New COVID-19 variants raise questions around vaccines, WHO says

Tedros described the development as “concerning news”, though noting important caveats related to the study.

TBS Report 
09 February, 2021, 09:50 am
Last modified: 09 February, 2021, 09:55 am
World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus Photo: BSS/AFP
World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus Photo: BSS/AFP

The emergence of new coronavirus variants has raised major questions around whether currently available vaccines will be effective against them, said the head of the World Health Organization (WHO).

WHO chief Tedros Adhanom Ghebreyesus was speaking on Monday one day after South Africa announced it was temporarily suspending rollout of the Oxford-AstraZeneca vaccine after a relatively small study revealed it provided reduced protection against the variant first identified in the country. 

Tedros described the development as "concerning news", though noting important caveats related to the study, reports UN News. 

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"These results are a reminder that we need to do everything we can to reduce circulation of the virus with proven public health measures", he said, speaking during WHO's latest press briefing from Geneva. 

"It also seems increasingly clear that manufacturers will have to adjust to the evolution of the virus, taking into account the latest variants for future shots, including boosters." 

The Oxford-AstraZeneca vaccine is among several found to be effective in preventing severe disease, hospitalization and death from COVID-19, said Tedros. 

The South African study showed it was minimally effective at preventing mild to moderate illness caused by the variant first identified there, known as 501Y.V2. 

"Given the limited sample size of the trial and the younger, healthier profile of the participants, it is important to determine whether or not the vaccine remains effective in preventing more severe illness", he told journalists. 
 
 

Top News

new variant / WHO / WHO Chief

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • BNP Chairperson Khaleda Zia virtually addressing an event on 29 May 2025, marking the death anniversary of BNP founder and former president Ziaur Rahman. Photo: Screengrab from BNP Media Cell video.
    Democracy still being obstructed at every step: Khaleda Zia
  • Bangladesh Engineering Industry Owners’ Association President Md Abdur Razzaque speaking at the inauguration ceremony of the Bangladesh Light Engineering Expo 2025 in Dhaka on 29 May 2025. Photo: TBS
    Like leather, light engineering sector also needs industrial park: Industry leaders
  • Representational Photo: TBS
    Deep depression halts cargo unloading at Ctg port's outer anchorage

MOST VIEWED

  • Dhaka areas at a gridlock on Wednesday, 28 May 2025. Photo: Syed Zakir Hossain/TBS
    BNP, Jamaat rallies: Traffic clogs Dhaka roads, including Motijheel, Paltan, Dainik Bangla intersection
  • IFIC Bank receives Tk6,000 cr in new deposits in six months
    IFIC Bank receives Tk6,000 cr in new deposits in six months
  • Mohammad Abdul Mannan, chairman FSIB Ltd. Sketch: TBS
    FSIB to bounce back soon
  • Abdul Awal Mintoo, chairman of National Bank Limited. Sketch: TBS
    'Regulatory support must for National Bank to restore depositors' confidence'
  • Md Nazrul Islam Swapan, chairman of EXIM Bank. Sketch: TBS
    Exim Bank restored depositors’ confidence, overcoming challenges
  • Mohammad Mamdudur Rashid, managing director and CEO, UCB. Sketch: TBS
    Customers’ trust and confidence fueling deposit growth at UCB

Related News

  • Uncertainty in aid commitments threatens Bangladesh's progress in maternal health: UNICEF, UNFPA, WHO
  • 'History will not forgive' failure to seal pandemic deal: WHO chief
  • Japan provides $3.2m to WHO as assistance to ensure quality health services in Cox's Bazar, Bhasan Char
  • Argentina to withdraw from WHO after Trump exit, citing 'deep differences'
  • WHO proposes budget cut after US exit, defends its work

Features

For hundreds of small fishermen living near this delicate area, sustainable fishing is a necessity for their survival. Photo: Syed Zakir Hossain

World Ocean Day: Bangladesh’s ‘Silent Island’ provides a fisheries model for the future

2h | The Big Picture
The university will be OK. But will the US? Photo: Bloomberg

A weaker Harvard is a weaker America

2h | Panorama
The Botanical Garden is a refuge for plant species, both native and exotic. Photo: Mehedi Hasan/TBS

The hidden cost of 'development' in the Botanical Garden

2h | Panorama
Stillbirths in Bangladesh: A preventable public health emergency

Stillbirths in Bangladesh: A preventable public health emergency

2h | Panorama

More Videos from TBS

News of The Day, 29 MAY 2025

News of The Day, 29 MAY 2025

1h | TBS News of the day
Businesses set for relief as interim govt eyes major tax & fine cuts

Businesses set for relief as interim govt eyes major tax & fine cuts

4h | TBS Insight
Love is essential for human life

Love is essential for human life

3h | TBS Programs
What Should Be the Interim Government’s Budget Priority?

What Should Be the Interim Government’s Budget Priority?

2h | TBS Economy
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net